Eva Roblegg

Has grant

Graz University of Technology
Country flagAustria

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Development of advanced structures via 3D-printing for pharmaceutical inserts and implants

Open Date: 2022-01-01

Close Date: 2025-01-01

Grant: Close

Active organotypic models for nanoparticle toxicological screening

Open Date: 2019-08-01

Close Date: 2023-07-31

Grant: Close

Pharmacokinetic profiling of silver nanoparticles: the role of biological barriers

Open Date: 2018-01-01

Close Date: 2019-12-01

Grant: Close

Rationale Formulierungsentwicklung zur Steigerung die Wirksamkeit, Sicherheit und der Qualität von Arzneimitteln

Open Date: 2018-01-01

Close Date:

Grant: Close

Entwicklung und Charakterisierung von druckbaren Nanosuspensionen zur buccalen Anwendung

Open Date: 2013-09-01

Close Date: 2016-11-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

The exposure to inhaled carbon nanotubes (CNT) may have adverse effects on workers upon chronic exposure. In order to assess the toxicity of inhaled nanoparticles in a physiologically relevant manner, an air–liquid interface culture of mono and cocultures of respiratory cells and assessment in reconstructed bronchial and alveolar tissues was used. The effect of CNT4003 reference particles applied in simulated lung fluid was studied in bronchial (Calu-3 cells, EpiAirway™ and MucilAir™ tissues) and alveolar (A549 +/−THP-1 and EpiAlveolar™ +/−THP-1) models. Cytotoxicity, transepithelial electrical resistance, interleukin 6 and 8 secretion, mucociliary clearance and ciliary beating frequency were used as readout parameters. With the exception of increased secretion of interleukin 6 in the EpiAlveolar™ tissues, no adverse effects of CNT4003 particles, applied at doses corresponding to the maximum estimated lifetime exposure of workers, in the bronchial and alveolar models were noted, suggesting no marked differences between the models. Since the doses for whole-life exposure were applied over a shorter time, it is not clear if the interleukin 6 increase in the EpiAlveolar™ tissues has physiological relevance.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Reingard Raml

deputy head of reserch group

Joanneum Research

AUSTRIA
View details

Elisabeth Fink

Research Center Pharmaceutical Engineering GmbH

AUSTRIA
View details

Peter Banzer

Full profesor and team leader

Graz University of Technology

AUSTRIA
View details

Michael Grimm

University of Greifswald

GERMANY
View details

Werner Weitschies

Professor of Biopharmaceutics

University of Greifswald

GERMANY
View details

Eleonore Fröhlich

Medical University of Graz

AUSTRIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.